SCHEMBL7632391

SCHEMBL7632391

COC(=O)c1cc(OC)c(OC)c(OS(=O)(=O)c2ccc(C)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
ALDH1A1 P00352 4/20 0.50
LMNA P02545 3/20 0.50
HTT P42858 3/20 0.50
MAPT P10636 3/20 0.50
GAA P10253 1/20 0.49
GFER P55789 1/20 0.48
MEN1 O00255 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
TCF4 P15884 1/20 0.45
CTNNB1 P35222 1/20 0.45
CYP2C9 P11712 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7931629 0.88 ALDH1A1 (0.53) KMT2AALDH1A1LMNAHTTMAPT
SCHEMBL31013995 0.84 CYP2C9 (0.50) KMT2AALDH1A1LMNAHTTMAPT
SCHEMBL7632373 0.83 GAA (0.53) KMT2AALDH1A1LMNAHTTGAA
SCHEMBL2231769 0.79 ALDH1A1 (0.53) KMT2AALDH1A1LMNAGAAMEN1
SCHEMBL6496116 0.79 CYP1A1 (0.52) KMT2AALDH1A1LMNAHTTMAPT
SCHEMBL7632562 0.79 ALDH1A1 (0.78) KMT2AALDH1A1LMNAHTTMAPT
SCHEMBL7632566 0.79 ALDH1A1 (0.78) KMT2AALDH1A1LMNAHTTMAPT
Methyl Syringate SCHEMBL211747 0.78 MEN1 (0.61) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL7636534 0.78 ALDH1A1 (0.48) KMT2AALDH1A1LMNAHTTMAPT
SCHEMBL7630261 0.77 KMT2A (0.46) KMT2AALDH1A1LMNAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6459001-B1 Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them AVENTIS PHARMA S.A. (FR) 2002-10-01 US disclosed
US-6268520-B1 USED FORPREPARATION OF OPTICALLY ACTIVE OR RACEMIC COLCHICINE AND THIOCOLCHICINE DERIVATIVES HOECHST MARION ROUSSEL (FR) 2001-07-31 US disclosed
US-6221907-B1 Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same HOECHST MARION ROUSSEL (FR) 2001-04-24 US disclosed